(Reuters) - Netherlands-based biopharmaceutical firm Halix B.V. said on Tuesday it has signed an agreement with AstraZeneca to commercially manufacture the COVID-19 vaccine being developed by the drugmaker and the University of Oxford.
Under the agreement, Halix said it will manufacture the AZD1222 vaccine at a facility in the Netherlands.
Halix and AstraZeneca did not immediately respond to a Reuters request for more details.
Reporting by Tanishaa Nadkar and Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta
Bagikan Berita Ini
0 Response to "Halix to manufacture AstraZeneca's COVID-19 vaccine in Netherlands - Reuters UK"
Post a Comment